|
Market Closed -
Euronext Paris
10:25:00 20/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 85.30 EUR | -0.42% |
|
-3.05% | +36.70% |
| 09/11 | Fitch Affirms Eurofins Scientific on Strong Business Risk Profile | MT |
| 26/10 | Eurofins Scientific, Heading for a Sixth Consecutive Gain |
Company Valuation: Eurofins Scientific SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 20,893 | 12,900 | 11,336 | 9,273 | 11,036 | 14,569 | - | - |
| Change | - | -38.26% | -12.13% | -18.2% | 19.02% | 32.01% | - | - |
| Enterprise Value (EV) 1 | 23,132 | 15,739 | 14,041 | 12,269 | 14,677 | 17,997 | 17,647 | 17,294 |
| Change | - | -31.96% | -10.79% | -12.62% | 19.63% | 22.62% | -1.95% | -2% |
| P/E | 27.8x | 22.2x | 45.4x | 26.9x | 28x | 27.9x | 22.2x | 18.7x |
| PBR | 4.49x | 2.7x | 2.24x | 1.73x | 2.56x | 3.14x | 2.84x | 2.6x |
| PEG | - | -1x | -0.8x | 0.7x | 1.3x | 0.7x | 0.9x | 1x |
| Capitalization / Revenue | 3.11x | 1.92x | 1.74x | 1.33x | 1.51x | 1.93x | 1.82x | 1.71x |
| EV / Revenue | 3.44x | 2.34x | 2.16x | 1.77x | 2.01x | 2.38x | 2.2x | 2.02x |
| EV / EBITDA | 12.2x | 10.4x | 10.3x | 7.91x | 8.94x | 10.1x | 9.14x | 8.28x |
| EV / EBIT | 15.7x | 15.2x | 16.7x | 12.1x | 13.6x | 15.7x | 13.8x | 12.3x |
| EV / FCF | 22.8x | 23.2x | 29.6x | 15.3x | 16.7x | 21.9x | 19.3x | 17.3x |
| FCF Yield | 4.39% | 4.3% | 3.38% | 6.53% | 5.97% | 4.57% | 5.19% | 5.79% |
| Dividend per Share 2 | 1 | 1 | 0.5 | 0.5 | 0.72 | 0.8002 | 0.9166 | 0.9653 |
| Rate of return | 0.92% | 1.49% | 0.85% | 1.01% | 1.15% | 0.94% | 1.07% | 1.13% |
| EPS 2 | 3.91 | 3.02 | 1.3 | 1.83 | 2.23 | 3.061 | 3.85 | 4.55 |
| Distribution rate | 25.6% | 33.1% | 38.5% | 27.3% | 32.3% | 26.1% | 23.8% | 21.2% |
| Net sales 1 | 6,718 | 6,712 | 6,515 | 6,951 | 7,296 | 7,568 | 8,022 | 8,543 |
| EBITDA 1 | 1,902 | 1,513 | 1,364 | 1,552 | 1,641 | 1,776 | 1,930 | 2,088 |
| EBIT 1 | 1,473 | 1,037 | 842 | 1,017 | 1,079 | 1,148 | 1,274 | 1,403 |
| Net income 1 | 783 | 606 | 310 | 406 | 475 | 547 | 675.3 | 783.7 |
| Net Debt 1 | 2,239 | 2,839 | 2,705 | 2,996 | 3,641 | 3,428 | 3,078 | 2,725 |
| Reference price 2 | 108.80 | 67.06 | 58.98 | 49.31 | 62.40 | 85.30 | 85.30 | 85.30 |
| Nbr of stocks (in thousands) | 1,92,035 | 1,92,365 | 1,92,194 | 1,88,049 | 1,76,864 | 1,70,792 | - | - |
| Announcement Date | 22/02/22 | 01/03/23 | 27/02/24 | 30/01/25 | 29/01/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 27.86x | 2.38x | 10.13x | 0.94% | 1.6TCr | ||
| 16.7x | 6.32x | 12.11x | 1.79% | 6.37TCr | ||
| 31.66x | 8.45x | 27.93x | 0.07% | 5.86TCr | ||
| 37.7x | 6.72x | 20.09x | 0.86% | 5.42TCr | ||
| 40.47x | 5.8x | 27.69x | -.--% | 4.47TCr | ||
| 32.09x | 3.11x | 13.42x | -.--% | 4.05TCr | ||
| 36.32x | 8.88x | 23.19x | 0.36% | 3.63TCr | ||
| -19.54x | 51.81x | -20.9x | -.--% | 3.49TCr | ||
| 41.15x | 7.94x | 26.62x | -.--% | 3.23TCr | ||
| -87.55x | 16.38x | -94.1x | -.--% | 3.1TCr | ||
| Average | 15.69x | 11.78x | 4.62x | 0.4% | 4TCr | |
| Weighted average by Cap. | 18.84x | 11.11x | 8.47x | 0.47% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ERF Stock
- Valuation Eurofins Scientific SE
Select your edition
All financial news and data tailored to specific country editions
















